The value added of chemical and pharmaceutical products in Sweden witnessed notable fluctuations from 2013 to 2023, showing a general trend of recovery and modest growth over the last five years. After a notable decline from 2013 to 2017, a significant increase in 2019 marked a turning point. Despite a slight dip in 2020, the sector recorded consistent growth from 2021 to 2023, reaching an estimated value of 80.56 Billion Swedish Kronas in 2023. The year-on-year variations stabilized, showing an increase each year since 2021, with the latest variation being 0.99% in 2023. The compound annual growth rate (CAGR) over the past five years stood at 4.42%, indicating a steady recovery and growth trajectory.
Future trends to watch for include:
- Continued moderate growth with a forecasted CAGR of 0.79% over the next five years.
- Potential impacts of global supply chain disruptions on production and value addition in the sector.
- Emerging innovations and advancements in pharmaceuticals and specialty chemicals driving growth.
- Increased regulatory scrutiny and environmental considerations possibly affecting operational dynamics.
